Explore advancements in drug development, target selection, molecular biology discoveries, and early clinical trials for patients/caregivers/public or researchers/professionals, with filter options available. AACR, NCI, and EORTC experts provide insights. AACR also addresses recent political decisions affecting conference venues. The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (MToCT) is a premier annual conference that brings together scientists, clinicians, and industry representatives to discuss the latest advances in cancer research and treatment. The 2023 MToCT conference will be held on October 11-15, 2023 at the Hynes Convention Center in Boston, Massachusetts. The theme of the 2023 MToCT conference is "Precision Cancer Medicine: Discoveries to Delivery." The conference will feature a variety of sessions on topics such as: The latest advances in cancer genomics and molecular biology Emerging therapeutic targets and drug discovery strategies Clinical trials of novel cancer therapies Biomarkers for predicting tumor response and resistance to therapy Cancer immunotherapy And more The MToCT conference will also feature keynote speakers, panel discussions, and networking opportunities. In addition, there will be an exhibit hall where attendees can learn about the latest products and services from industry partners. The MToCT conference is a valuable opportunity for researchers and clinicians to stay up-to-date on the latest advances in cancer research and treatment, to learn from experts, and to network with colleagues from around the world. Why is the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 important? Cancer is a complex disease that is caused by a variety of genetic and environmental factors. In recent years, there has been significant progress in understanding the molecular basis of cancer. This progress has led to the development of new targeted therapies that are more effective and less toxic than traditional chemotherapy and radiation therapy. The MToCT conference is important because it provides a forum for scientists, clinicians, and industry representatives to discuss the latest advances in cancer research and treatment, with a focus on precision cancer medicine. Precision cancer medicine is an approach to cancer treatment that takes into account the individual genetic and molecular characteristics of a patient's tumor. This allows clinicians to select the most effective therapies for each patient, based on the specific molecular targets that are driving their cancer. Who should attend the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023? The MToCT conference is open to all researchers and clinicians who are interested in learning about the latest advances in cancer research and treatment, with a focus on precision cancer medicine. This includes: Cancer researchers Cancer clinicians Industry representatives Trainees and students How to register for the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 Registration for the MToCT 2023 conference will open in August 2023. To register, please visit the AACR website. I hope this information is helpful. Please let me know if you have any other questions.